Melanyze, Inc.
PrivateCompany Overview
Melanyze, Inc. is a biotechnology company developing patented synthetic melanin-based nanoparticle technologies for skin regeneration, wound repair, and the treatment of complex inflammatory skin conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
synthetic melaninnanoparticle technologywound healingbiomimicrytopical therapyskin regenerationbiotech startupdermatologyradical scavenginginflammatory skin diseasepreclinical biotechtissue repairbiocompatible materialsdrug discoveryregenerative medicine
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Melanyze, Inc. Comparables
Compare Melanyze, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioMimir Inc. | 69% | |
| SolasCure | 64% | |
| Almirall | 61% | |
Melanyze, Inc. Funding Rounds
Historical fundraising activity
Melanyze, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Melanyze, Inc.'s valuation, stock price, and market status.
Firmographic Details
HeadquartersChicago, Illinois
Employee Range4
Year Founded2023
Last Funding—
See something wrong or outdated?